Arizona Medicaid Committee Must Disclose Drug-Company Ties

July 30, 2018, 7:17 PM UTC

Arizona wants to limit the influence pharmaceutical companies have on the drugs the state chooses for preferred coverage by its Medicaid program, under a new executive order.

The directive issued July 27 by Gov. Doug Ducey (R) follows a national investigation by the Center for Public Integrity and NPR into how the industry influences the health-care program for low-income people. It found Janssen and Otsuka were among the companies paying a member of Arizona’s Pharmacy and Therapeutics Committee, who collected hundreds of thousands of dollars for work over several years.

Ducey’s order seeks to increase transparency of that committee, which ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.